Born in Argentina, Eduardo co-founded seven Israeli high-tech companies (Optibase, Vcon, Accord, Lasercomm, Big Band, Sirica, accells) with five successful exits, four of them with valuations in excess of $400 million and total revenues of billions of dollars.
Optibase was a pioneer in MPEG digital compression and forever changed the way we consume video on the Internet. Successfully taken public on NASDAQ in 1999, valuation peaked at over $400M. Eduardo’s six original employees at Optibase went on to create other successful high-tech ventures and Optibase became recognized as a boot camp for entrepreneurial activity in Israel.
Accord, a leader in rich media video network products, was acquired by Polycom in 2000 for $400M. Vcon, a video conferencing pioneer that went public in France on the Nouveau Marche and reached a market cap of $400M. Big Band Networks, a leader in cable and satellite video distribution, peaked at a $750M market cap on NASDAQ and was acquired in 2011 by Arris.
Originally from Jerusalem, Yori was the founder and CEO of Banter, a pioneering natural language processing company. He successfully established the company as a leader in the call-center space, serving some of the largest US banks (including Wells Fargo and Bank of America), until its acquisition by IBM. After selling Banter in 2004, Yori joined the Mayfield Fund in Silicon Valley as entrepreneur-in-residence, where he provided deal flow and due-diligence support as well as portfolio mentoring. In 2005, Yori founded TimeBridge, a pre-cloud calendar management assistant, an early example of successful viral promotion within a corporate setting. With a corporate user base of millions of users, TimeBridge was acquired by MerchantCircle.
Yori also co-founded Local Sciences, a local data-as-a-service provider, successfully engineering its pivot to become a broad data collection and analysis technology. Local Sciences quickly became the largest accurate local database for service businesses in the Health & Beauty and Automotive verticals, providing data to YP, Groupon and other industry leaders. Yori returned to Israel and joined OurCrowd after living in the Bay Area for 14 years.
Avi is General Partner at OurCrowd First, israel’s most active early-stage venture fund, seeding and scaling high-tech companies that are computing and actuating the connected world. OCF attracts extraordinary entrepreneurs with innovative technologies seeking to disrupt huge markets in our areas of expertise.
Avi is also the Founder, Chairman and Chief Executive Officer of XponentialWorks™, a venture investment and product development company that is monetizing the upside of disruption from exponential-tech convergence.
For the previous twelve years, Avi served as 3D Systems (NYSE:DDD) President, Chief Executive Officer and Director. Under Avi’s leadership, 3D Systems emerged as a formidable global 3D printing provider with revenue growth exceeding 6 fold and market valuation growing over 12 fold. During his tenure the company was ranked the 13th most Innovative Growth Company in the world by Forbes in 2014 and was named the 5th Fastest Growing Company in the U.S. and the country’s 2nd Fastest Growing Tech Company by Fortune Magazine in 2013.
For the preceding twenty-two years, Avi held senior executive leadership positions with Sealed Air (NYSE:SEE) a leading global provider of food safety and security, facility hygiene, and product protection solutions.
Currently, Avi sits on the Board of Directors of Harman International (NYSE: HAR) a leading provider of connected products.
Avi is also Founder and Chairman of Centaur, ElasticMedia, Nexa3D, and Apollo Robotics. In 2014 Avi was named as one of the Top 25 Makers Who Are Reinventing the American Dream by Popular Mechanics Magazine. The same year he delivered a visionary TED talk titled ‘what’s next in 3D printing’ that was already viewed by over 2.4 million viewers. In 2013, Avi was listed as one of Fortune Magazine’s Top 50 business leaders, in 2012, he received the Financial Times Boldness in Business award and in 2011 he was a recipient of the 2011 E&Y Regional Entrepreneur of the Year Award.
Avi is an active inventor who holds 25 patents. He is part of Singularity University’s core faculty, serves as a Trustee of Cooper-Hewitt Smithsonian’s Design Museum and is a member of the XPRIZE Innovation Board.
Dr. Yossi Bahagon
Dr. Yossi Bahagon is an active family physician who founded and managed the digital health division at Clalit Health Services – the second largest health maintenance organization in the world. Clalit’s digital health platform became an international benchmark in vision, strategy and execution aspects, being used by over 2 million monthly users, who generate over 4 million monthly interactions. Following Clalit, Yossi founded Luminox, a strategic digital health consulting firm and startup hub that served the largest international pharma, healthcare providers and insurers companies. Yossi handpicked and seeded six successful digital health startups. These startups grew in aggregate value from single digit to hundreds of millions in the last 4 years, and were backed by leading VCs and corporate funds including Philips, Qualcomm Ventures, Orbimed, Walgreens, Fuson Pharma and Pitango.
Allen is a successful entrepreneur and experienced corporate executive in the healthcare and medical informatics space. He recently joined OurCrowd as a Managing Partner to launch its first sector fund focused exclusively on investments in digital health. Previously, Allen was a co-founder of Humedica, a transformative population health and analytics company which was sold to UnitedHealth (NYSE UNH - the largest U.S. health insurer) in 2013. Following the acquisition, Allen served as the Chief Commercial Officer of Optum Analytics (a division in Optum, UnitedHealth Group’s health services company). As the CCO, he led the group’s commercialization efforts of analytics software products and solutions, including the award-winning Optum OneTM, to U.S. provider and payer organizations. With nearly 25 years of experience in health care, Allen also was a director at leading healthcare investment bank, Leerink Swann (now Leerink Partners), and held management positions at Biogen. He began his career reporting on FDA and policy issues for The Pink Sheet, and received his BA from Brandeis University.